PRENOM II : Pregnancy remote monitoring of women at risk for gestational hypertensive disorders (R-9297)

The goal of this project is to thoroughly evaluate the added value of a remote monitoring (RM) program for women at risk for gestational hypertensive disorders (GHD), by conducting a multicenter randomized controlled trials at 4 MIC centers in Flanders, and investigating its impact on prenatal follow-up, health outcomes for mother and child, costs and satisfaction. With PREMOM II, we want to complete the following triple aim: 1) Improvement of the health: less complications for the mother and the neonate due to GHD 2) Improvement of the quality of care: an early detection of (the development of) GHD and a more intensively follow-up for the women who need this. 3) A reduction of the health cost per capita: less consumption of care, less consultations and hospitalizations, a reduction of cost due to complications for both the mother and child. Our specific objectives are: - A multicentric, pragmatic RCT in four Flemish MIC departments: this to investigate the impact of RM in a prenatal follow-up program for women with GD on: (1) prenatal follow-up and health care consumption: (2) pregnancy outcomes, for both the mother and the neonate; (3) costs for the health care society, both on the long-term and on the short-term. - Trying to understand which is exactly the added value of RM by (1) set up a group of pregnant women which measure their vital parameters by themselves, but without the supervision of a midwife; (2) by the consequent registration of the timing of the interventions and their effects on the blood pressure and the development of GHD. - Questioning the satisfaction and the perceptions of the midwives, the obstetricians and the recently delivered women regarding their prenatal follow-up - A cost - effectiveness analysis and the willingness to pay of this prenatal follow-up program.

Keywords:gestational hypertensive disorders, pregnancy, remote monitoring

Disciplines:Biophysics